SCFAs butyrate, propionate, acetate 4
Yanai H, Adachi H, Hakoshima M, Katsuyama H (2024) Pathology and Treatments of Alzheimers Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed for type 2 diabetes management and, more recently, for chronic weight management
The Hidden Limitations of GLP-1-Only Weight Loss 1
They enable significant weight loss, reduce cardiovascular events and show promise for conditions from Alzheimer's to addiction
Current View Current View Enter the password to open this PDF file: File name: - File size: - Title: - Author: - Subject: - Keywords: - Creation Date: - Modification Date: - Creator: - PDF Producer: - PDF Version: - Page Count: - Page Size: - Fast Web View: - Preparing document for printing 0%